Most supplements treat the symptom.
We treat the cause.
Upstream means acting on the root cause before symptoms become damage. It is the only position worth owning in nutrition.
Joint pain doesn't start in your joints.
The supplement industry has spent decades targeting joints directly — glucosamine for cartilage, collagen for tissue, anti-inflammatories for pain. All of it downstream. All of it treating consequences rather than causes.
The research now points somewhere different. For a significant proportion of people, the inflammation that damages joints originates in the gut. A compromised gut barrier allows inflammatory triggers into the bloodstream. They circulate. They land in connective tissue and joints. The gut was the problem. The joint is just where you feel it.
Upstream means addressing that. Not waiting for the joint to deteriorate and then managing it — but supporting the system that drives the problem in the first place, while the window to act is still open.
One sachet.
Both ends of the chain.
LYVA Flex is a daily sachet that addresses the gut-joint axis at both ends. Microbiome support upstream, and downstream ingredients studied in relation to joint tissue. We use the specific forms used in published research.
Not a gut health product. Not a joint product. A product that understands the two are connected — and formulated accordingly.
See LYVA Flex →Short-chain fatty acid support
A prebiotic blend is fermented by gut bacteria into short-chain fatty acids — the molecules researchers are investigating in relation to cartilage and subchondral bone via the gut-joint axis.
Microbiome modulation
The prebiotic blend feeds gut bacteria — the upstream source of the short-chain fatty acids under investigation in relation to cartilage and subchondral bone.
Joint environment support
Curcumin BCM-95 and Boswellia address the inflammatory environment at the joint — in the clinical-grade, bioavailable forms used in published trials.
Mechanism first.
Marketing second.
Always.LYVA · Upstream